Orasis Pharmaceuticals
Julie Speed brings over two decades of proven ophthalmic leadership across both pharmaceutical and medical device. Her expertise spans from commercial leadership positions at Alcon and Johnson & Johnson Vision-Surgical, progressing commercial strategy and brands, to start-up organizations at Eyevance and TearLab, building marketing strategy and teams from the ground up. Her broad marketing and launch experience with U.S. and global brands will help accelerate Orasis towards launch readiness.
Ms. Speed earned her B.S. in Biomedical Science from Texas A&M University and MBA from Texas Christian University.
This person is not in any teams
This person is not in any offices
Orasis Pharmaceuticals
2 followers
Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.